60 results
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding expectations for the Company’s
8-K
EX-99.1
VERV
Verve Therapeutics Inc
27 Feb 24
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties, including statements regarding the company’s
ability
8-K
crj9g6jrortgndgaqn
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
EX-1.1
l4xznli 5vw
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
EX-99.1
m6f9e
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
8-K
54j7o0zbdhn8fz3ad9
13 Nov 23
Other Events
6:34am
8-K
EX-99.1
l20v7h 42
7 Nov 23
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
7:00am
8-K
syoz hfkwjep8vl
23 Oct 23
Other Events
6:41am
8-K
EX-99.1
5bvc9k
10 Aug 23
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
7:00am
8-K
2ayfu5e8z
15 Jun 23
Entry into a Material Definitive Agreement
6:37am
8-K
EX-99.1
chr9he y73mp
15 May 23
Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results
7:00am
8-K
kj2pzix6
5 Dec 22
Other Events
6:47am